Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-24-000037
Filing Date
2024-01-23
Accepted
2024-01-23 15:04:57
Documents
43
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q sybe123123form10q.htm   iXBRL 10-Q 600815
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8761
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 10251
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4916
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4927
11 EXHIBIT 10.19 ex10_19.htm EX-10.19 2526
  Complete submission text file 0001607062-24-000037.txt   2274712

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sybe-20231230.xsd EX-101.SCH 23620
7 XBRL CALCULATION FILE sybe-20231230_cal.xml EX-101.CAL 32463
8 XBRL DEFINITION FILE sybe-20231230_def.xml EX-101.DEF 42352
9 XBRL LABEL FILE sybe-20231230_lab.xml EX-101.LAB 158182
10 XBRL PRESENTATION FILE sybe-20231230_pre.xml EX-101.PRE 122641
37 EXTRACTED XBRL INSTANCE DOCUMENT sybe123123form10q_htm.xml XML 201448
Mailing Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465
Business Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465 718-795-7790
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-248059 | Film No.: 24552211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)